HTG Completes HTP Product Next-Phase Development Milestone

Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. , Dec. 22, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology,